These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 29903248)
1. [Inhibition of WIP1 in A549 cells enhances the sensitivity of cells to arsenic treatment]. Luo Q; Gu S; Zhang Z Wei Sheng Yan Jiu; 2017 May; 46(3):389-395. PubMed ID: 29903248 [TBL] [Abstract][Full Text] [Related]
2. [Improving the expression of TP53INP1 in A549 cells enhances the sensitivity of cells to arsenic treatment]. Luo Q; Gu S; Li Y; Zhang Z Wei Sheng Yan Jiu; 2017 Jan; 46(1):120-125. PubMed ID: 29903164 [TBL] [Abstract][Full Text] [Related]
3. p53-Independent expression of wild-type p53-induced phosphatase 1 (Wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors. Park JY; Song JY; Kim HM; Han HS; Seol HS; Jang SJ; Choi J Int J Biochem Cell Biol; 2012 Jun; 44(6):896-904. PubMed ID: 22405851 [TBL] [Abstract][Full Text] [Related]
4. Involvement of dysregulated Wip1 in manganese-induced p53 signaling and neuronal apoptosis. Ma X; Han J; Wu Q; Liu H; Shi S; Wang C; Wang Y; Xiao J; Zhao J; Jiang J; Wan C Toxicol Lett; 2015 May; 235(1):17-27. PubMed ID: 25791630 [TBL] [Abstract][Full Text] [Related]
5. Expression of a homeostatic regulator, Wip1 (wild-type p53-induced phosphatase), is temporally induced by c-Jun and p53 in response to UV irradiation. Song JY; Han HS; Sabapathy K; Lee BM; Yu E; Choi J J Biol Chem; 2010 Mar; 285(12):9067-76. PubMed ID: 20093361 [TBL] [Abstract][Full Text] [Related]
6. Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xL ratio. Goloudina AR; Mazur SJ; Appella E; Garrido C; Demidov ON Cell Cycle; 2012 May; 11(10):1883-7. PubMed ID: 22544321 [TBL] [Abstract][Full Text] [Related]
7. Expression of Wip1 in kidney carcinoma and its correlation with tumor metastasis and clinical significance. Sun GG; Wang YD; Liu Q; Hu WN Pathol Oncol Res; 2015 Jan; 21(1):219-24. PubMed ID: 24970693 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of Wild-Type p53-Induced Phosphatase 1 Confers Poor Prognosis of Patients with Nasopharyngeal Carcinoma. Sun GG; Zhang J; Ma XB; Wang YD; Cheng YJ; Hu WN Pathol Oncol Res; 2015 Apr; 21(2):283-91. PubMed ID: 25060857 [TBL] [Abstract][Full Text] [Related]
9. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression. Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816 [TBL] [Abstract][Full Text] [Related]
10. Dose-dependent mutual regulation between Wip1 and p53 following UVC irradiation. Xia Y; Yang Q; Gong X; Ye F; Liou YC Int J Biochem Cell Biol; 2011 Apr; 43(4):535-44. PubMed ID: 21163364 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of Wip1 Enhances Sensitivity to Radiation in HeLa Cells Through Activation of p38 MAPK. Wang HY; Liu ZS; Qiu L; Guo J; Li YF; Zhang J; Wang TJ; Liu XD Oncol Res; 2014; 22(4):225-233. PubMed ID: 26351212 [TBL] [Abstract][Full Text] [Related]
12. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas. Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of wild-type p53-induced phosphatase 1 promotes liver regeneration in mice by direct activation of mammalian target of rapamycin. Zhang L; Liu L; He Z; Li G; Liu J; Song Z; Jin H; Rudolph KL; Yang H; Mao Y; Zhang L; Zhang H; Xiao Z; Ju Z Hepatology; 2015 Jun; 61(6):2030-41. PubMed ID: 25704606 [TBL] [Abstract][Full Text] [Related]
14. Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma. Fuku T; Semba S; Yutori H; Yokozaki H Pathol Int; 2007 Sep; 57(9):566-71. PubMed ID: 17685927 [TBL] [Abstract][Full Text] [Related]
15. Wip1 deficiency impairs haematopoietic stem cell function via p53 and mTORC1 pathways. Chen Z; Yi W; Morita Y; Wang H; Cong Y; Liu JP; Xiao Z; Rudolph KL; Cheng T; Ju Z Nat Commun; 2015 Apr; 6():6808. PubMed ID: 25879755 [TBL] [Abstract][Full Text] [Related]
16. Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents. Goloudina AR; Tanoue K; Hammann A; Fourmaux E; Le Guezennec X; Bulavin DV; Mazur SJ; Appella E; Garrido C; Demidov ON Proc Natl Acad Sci U S A; 2012 Jan; 109(2):E68-75. PubMed ID: 22065775 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers. Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432 [TBL] [Abstract][Full Text] [Related]
18. The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene. Choi J; Appella E; Donehower LA Genomics; 2000 Mar; 64(3):298-306. PubMed ID: 10756097 [TBL] [Abstract][Full Text] [Related]
19. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Fujimoto H; Onishi N; Kato N; Takekawa M; Xu XZ; Kosugi A; Kondo T; Imamura M; Oishi I; Yoda A; Minami Y Cell Death Differ; 2006 Jul; 13(7):1170-80. PubMed ID: 16311512 [TBL] [Abstract][Full Text] [Related]
20. Proto-oncogene Wip1, a member of a new family of proliferative genes in NSCLC and its clinical significance. Fu Z; Sun G; Gu T Tumour Biol; 2014 Apr; 35(4):2975-81. PubMed ID: 24272082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]